These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30667373)

  • 1. Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice.
    Beckelman BC; Yang W; Kasica NP; Zimmermann HR; Zhou X; Keene CD; Ryazanov AG; Ma T
    J Clin Invest; 2019 Feb; 129(2):820-833. PubMed ID: 30667373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice.
    Kasica NP; Zhou X; Yang Q; Wang X; Yang W; Zimmermann HR; Holland CE; Koscielniak E; Wu H; Cox AO; Lee J; Ryazanov AG; Furdui CM; Ma T
    J Neurochem; 2022 Mar; 160(5):524-539. PubMed ID: 34932218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.
    Yang W; Zhou X; Ryazanov AG; Ma T
    Neurobiol Aging; 2021 Feb; 98():225-230. PubMed ID: 33341653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome.
    Wang X; Yang Q; Zhou X; Keene CD; Ryazanov AG; Ma T
    Alzheimers Dement; 2024 Aug; 20(8):5357-5374. PubMed ID: 38934363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.
    Ma T; Chen Y; Vingtdeux V; Zhao H; Viollet B; Marambaud P; Klann E
    J Neurosci; 2014 Sep; 34(36):12230-8. PubMed ID: 25186765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease.
    Ma T
    J Neurochem; 2023 Jul; 166(1):47-57. PubMed ID: 34796967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer's disease model mice independent of brain amyloid β pathology.
    Kasica NP; Zhou X; Jester HM; Holland CE; Ryazanov AG; Forshaw TE; Furdui CM; Ma T
    Front Aging Neurosci; 2022; 14():959326. PubMed ID: 36158543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia.
    McCamphill PK; Ferguson L; Sossin WS
    J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis.
    Verpelli C; Piccoli G; Zibetti C; Zanchi A; Gardoni F; Huang K; Brambilla D; Di Luca M; Battaglioli E; Sala C
    J Neurosci; 2010 Apr; 30(17):5830-42. PubMed ID: 20427644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy.
    Vilchinskaya N; Lim WF; Belova S; Roberts TC; Wood MJA; Lomonosova Y
    Am J Pathol; 2023 Jun; 193(6):813-828. PubMed ID: 36871751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of eEF2 kinase improves deficits in novel object recognition memory in aged mice.
    Gosrani SP; Jester HM; Zhou X; Ryazanov AG; Ma T
    Neurobiol Aging; 2020 Nov; 95():154-160. PubMed ID: 32810756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.
    Bianco C; Thompson L; Mohr I
    Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions.
    Rose AJ; Alsted TJ; Jensen TE; Kobberø JB; Maarbjerg SJ; Jensen J; Richter EA
    J Physiol; 2009 Apr; 587(Pt 7):1547-63. PubMed ID: 19188248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing Ribosomal Protein S6 Kinase 1 Expression Improves Spatial Memory and Synaptic Plasticity in a Mouse Model of Alzheimer's Disease.
    Caccamo A; Branca C; Talboom JS; Shaw DM; Turner D; Ma L; Messina A; Huang Z; Wu J; Oddo S
    J Neurosci; 2015 Oct; 35(41):14042-56. PubMed ID: 26468204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain.
    Li X; Alafuzoff I; Soininen H; Winblad B; Pei JJ
    FEBS J; 2005 Aug; 272(16):4211-20. PubMed ID: 16098202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease.
    Beckelman BC; Day S; Zhou X; Donohue M; Gouras GK; Klann E; Keene CD; Ma T
    J Alzheimers Dis; 2016 Sep; 54(2):669-78. PubMed ID: 27567813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
    Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
    J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermal injury activates the eEF2K-dependent eEF2 pathway in pediatric patients.
    Song J; Finnerty CC; Herndon DN; Kraft R; Boehning D; Brooks NC; Tompkins RG; Jeschke MG
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):596-602. PubMed ID: 22269896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response.
    Jan A; Jansonius B; Delaidelli A; Somasekharan SP; Bhanshali F; Vandal M; Negri GL; Moerman D; MacKenzie I; Calon F; Hayden MR; Taubert S; Sorensen PH
    Acta Neuropathol; 2017 Jan; 133(1):101-119. PubMed ID: 27752775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.